Table 1 Demographic and clinical characteristics of European American participants with type 2 diabetes, stratified by mortality status
|  | Full Sample (n = 1022) | Living (n = 703) | Deceased (n = 319) | |||
|---|---|---|---|---|---|---|
Trait | Mean (SD) or % | Median (range) | Mean (SD) or % | Median (range) | Mean (SD) or % | Median (range) |
Age (years) | 62.43 (9.07) | 62.80 (34.21, 85.98) | 60.64 (8.48) | 60.54 (34.21, 81.77) | 66.36 (9.09) | 67.03 (34.34, 85.98) |
Female Sex (%) | 51.5Â % | Â | 54.8Â % | Â | 44.2Â % | Â |
Current Smoking (%) | 16.1Â % | Â | 14.0Â % | Â | 20.8Â % | Â |
Past Smoking (%) | 43.4Â % | Â | 43.6Â % | Â | 43.1Â % | Â |
History of Cardiovascular Disease (%) | 43.2Â % | Â | 37.3Â % | Â | 56.1Â % | Â |
All-Cause Mortality (%) | 31.2Â % | Â | 0Â % | Â | 100Â % | Â |
Cardiovascular Disease Mortality (%) | 14.3Â % | Â | 0Â % | Â | 47.8Â % | Â |
Educational Attainment- Less than High School (%) | 25.6Â % | Â | 20.8Â % | Â | 36.4Â % | Â |
Educational Attainment- High School (%) | 49.2Â % | Â | 51.4Â % | Â | 44.1Â % | Â |
Educational Attainment- Greater than High School (%) | 25.2Â % | Â | 27.8Â % | Â | 19.5Â % | Â |
Body Mass Index (kg/m2) | 32.38 (6.58) | 31.32 (17.10, 57.97) | 32.67 (6.40) | 31.61 (17.10, 57.97) | 31.75 (6.93) | 30.54 (17.54, 56.92) |
Waist Hip Ratio | 0.941 (0.082) | 0.944 (0.436, 1.246) | 0.937 (0.077) | 0.939 (0.648, 1.234) | 0.949 (0.091) | 0.955 (0.436, 1.246) |
Glucose (mg/dL) | 147.9 (56.15) | 135 (16, 463) | 145.6 (51.17) | 134 (16, 463) | 152.9 (65.60) | 140 (46, 436) |
Glycated Hemoglobin (%) | 7.60 (1.72) | 7.20 (4.30, 18.30) | 7.49 (1.61) | 7.10 (4.60, 16.40) | 7.84 (1.92) | 7.60 (4.30, 18.30) |
Diabetes Duration (years) | 10.42 (7.15) | 8 (0, 46) | 9.32 (6.39) | 7 (0, 46) | 12.80 (8.09) | 11 (1, 41) |
Coronary Artery Calcified Plaque (mass score) | 1856 (3335) | 449.5 (0, 50415) | 1328 (3038) | 256.5 (0, 50415) | 3048 (3657) | 1632 (0, 22378) |
Carotid Intima Media Thickness (mm) | 0.683 (0.136) | 0.659 (0.449, 1.569) | 0.664 (0.127) | 0.639 (0.449, 1.569) | 0.723 (0.144) | 0.700 (0.456, 1.316) |
Total Cholesterol (mg/dL) | 185.2 (43.42) | 181 (65, 427) | 184.5 (43.15) | 180 (65, 427) | 186.9 (44.04) | 183 (70, 386) |
HDL (mg/dL) | 42.16 (11.89) | 41 (8, 98) | 42.46 (11.59) | 41 (14, 94) | 41.49 (12.52) | 40 (8, 98) |
Triglycerides (mg/dL) | 208.9 (138.8) | 176 (30, 1310) | 206.0 (136.4) | 173 (30, 1310) | 215.3 (143.9) | 183 (30, 1065) |
LDL (mg/dL) | 103.0 (32.6) | 100 (12, 236) | 102.2 (32.4) | 100 (14, 207) | 104.9 (33.1) | 103 (12, 236) |
Pulse Pressure (mmHg) | 67.09 (16.93) | 65.5 (28, 159) | 65.53 (15.85) | 64 (28, 124) | 70.52 (18.67) | 69.5 (31, 159) |
Mean Arterial Pressure (mmHg) | 95.05 (11.24) | 94 (66.5, 154) | 95.19 (10.33) | 94 (66.5, 140.3) | 94.75 (13.02) | 93.17 (67.33, 154) |
Estimated Glomerular Filtration Rate (ml/min/1.73Â m2) | 65.76 (18.38) | 63.77 (8.91, 126.4) | 67.95 (17.86) | 65.43 (20.97, 122.2) | 60.96 (18.62) | 58.43 (8.91, 126.4) |
Urine Albumin:creatinine Ratio (mg/g) | 121.5 (530.5) | 14.29 (0.48, 9449) | 68.49 (390.8) | 11.57 (0.48, 8878) | 239.8 (741.5) | 23.08 (0.78, 9449) |
QT Interval (ms) | 393.8 (33.14) | 392.0 (270.1, 564.0) | 393.2 (32.27) | 392.0 (310.1, 564.0) | 395.0 (34.93) | 392.0 (270.1, 526.0) |
High Blood Pressure Medications (%) | 75.5Â % | Â | 72.0Â % | Â | 83.4Â % | Â |
Statin Use (%) | 42.7Â % | Â | 44.8Â % | Â | 37.9Â % | Â |
Oral Hypoglycemic Medications (%) | 78.8Â % | Â | 79.0Â % | Â | 78.4Â % | Â |
Insulin Use (%) | 27.3Â % | Â | 22.9Â % | Â | 37.0Â % | Â |
C-reactive Protein (mg/dL) | 0.611 (1.004) | 0.296 (0.005, 12.73) | 0.529 (0.793) | 0.28 (0.005,9.573) | 0.801 (1.355) | 0.353 (0.008,12.73) |
Biventricular Volume (ml) | 384.5 (112.1) | 375.6 (156.6, 884.5) | 372.0 (100.7) | 361.3 (156.6, 781.8) | 411.8 (129.7) | 397.2 (182.6, 884.5) |